VAXIN LAUNCHES JOINT VENTURE WITH ANC BIO IN KOREA
Impax Laboratories Settles Pending Litigation for FLOMAX(R)
Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc
Biovail Provides Update on Pimavanserin Collaborative Development Program
To keep up to date with news from this category use our
Flamel Technologies Announces Licensing Agreement with Pfizer
LYON, France--November 04, 2009 - Flamel Technologies (Nasdaq:FLML) today announced that Pfizer (NYSE: PFE) has exercised its option to license Flamel's Medusa
Thirteen Abstracts Featuring Exelixis Compounds Accepted for Presentation at the 2009 AACR-NCI-EORTC International Conference
SOUTH SAN FRANCISCO, Calif.-- November 4, 2009-- Exelixis, Inc. (Nasdaq: EXEL) announced today that thirteen abstracts related to the company's development candidates have been accepted for presentation at the 2009...
AGA Medical Receives Product Approvals in China
MINNEAPOLIS, Nov. 4, 2009 -- AGA Medical Holdings, Inc. (AGA Medical) (NASDAQ: AGAM) has received regulatory approvals and licenses in China for its AMPLATZER
Aerocrine and Panasonic Shikoku Electronics enter into asthma partnership
SOLNA, Sweden - 4 November 2009 - Aerocrine AB (OMX Nordic Exchange: AERO) today announced that Aerocrine and Panasonic Shikoku Electronics, CO., LTD (PSEC) have entered into a long-term agreement to develop,...
Aeolus Pharmaceuticals' AEOL 10150 Protects Lungs Against Chlorine Gas Exposure in Animal Studies
Mission Viejo, CA, November 4, 2009-- Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) reported that researchers from National Jewish Health and McGill University have completed a series of preliminary studies...
AtriCure Announces Tentative Settlement with the Department of Justice
WEST CHESTER, Ohio--Nov. 4, 2009-- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it has reached a tentative agreement, subject to...
Phase Forward Teams with PharmaNet Development Group
WALTHAM, Mass.---Nov. 4, 2009-- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with PharmaNet Development Group,...
Nabi Biopharmaceuticals Completes Sale of PentaStaph(TM) to GlaxoSmithKline PLC
ROCKVILLE, Md., November 4, 2009 -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced that it has completed the sale of PentaStaph(TM) (Pentavalent S. aureus Vaccine) and related assets to GlaxoSmithKline PLC (GSK). The...
Monsanto Opens First Biotechnology Research Center in China
ST. LOUIS and BEIJING, November 4, 2009 -- Monsanto Company (NYSE: MON) announced today that it is opening its first research center in China, further demonstrating its commitment to forming technology collaborations in...
FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease
04 Nov 2009 - Cambridge, MA - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has granted Priority Review...
NEW MERCK BEGINS OPERATIONS WORLDWIDE
WHITEHOUSE STATION, N.J. - November 4 2009 - Merck & Co., Inc. (NYSE: MRK) today outlined its global strategy following the completion yesterday of Merck's merger with Schering-Plough Corporation. The new Merck,...
Shire Extends Agreement with Medidata Solutions for Trial Planning Products
NEW YORK, N.Y. - November 4, 2009 - Medidata Solutions (NASDAQ: MDSO), a leading global provider of hosted clinical development solutions, today announced a multi-year contract extension with Shire plc (LSE: SHP,...
Foamix Extends Collaboration with Galderma
Rehovot (Israel), November 3, 2009 -- Foamix Ltd, a global leader in the development of dermatological foam medications today announced that the company has extended its agreement with Galderma to develop an innovative...
Lonza integrates Innovative Technology in its Protein Design Services offering
Basel, 3 November 2009 - Lonza strengthens its protein design technology offering for biopharmaceutical development by acquiring Algonomics NV (Gent, Belgium). Algonomics is a contract research organisation providing...
President of Tanzania and the Abbott Fund Dedicate Modern Emergency Medical Department
DAR ES SALAAM, Tanzania, Nov. 3, 2009 - For the first time, emergency room services meeting international standards will be a part Tanzania's public health system, thanks to the opening of a new Emergency Medical...
MERCK AND SCHERING-PLOUGH TO COMPLETE MERGER TODAY
WHITEHOUSE STATION and KENILWORTH, N.J.: November 3, 2009 - Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they will complete their merger shortly after 4:00PM ET today....
Merck and Schering-Plough to Complete Merger Today
WHITEHOUSE STATION and KENILWORTH, N.J., November 3, 2009 - Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they will complete their merger shortly after 4:00PM ET today....
Vironova receives nanomedicine grant
November 02, 2009 - Vironova is pleased to inform that the ERA-Net project titled I-CARE (Integrative nano-Composites And Regeneration of the Eye) has been recommended for funding. The research and development project...
Federal Court of Appeals Upholds Antitrust Liability Verdict Against Tyco HealthCare
Irvine, California - November 2, 2009 - Masimo (NASDAQ: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that the Ninth Circuit Court of Appeals...
Bayer CropScience completes acquisition of biotech company Athenix Corp.
Monheim, November 2, 2009 - Bayer CropScience announced today the completion of its purchase of Athenix Corp., a privately-held independent biotechnology company headquartered in Research Triangle Park, North Carolina,...
Bayer CropScience completes acquisition of biotech company Athenix Corp.
Monheim, November 2, 2009 - Bayer CropScience announced today the completion of its purchase of Athenix Corp., a privately-held independent biotechnology company headquartered in Research Triangle Park, North Carolina,...
Taisho Completes Purchase of Certain OTC Drug Trademarks and PT Bristol-Myers Squibb Indonesia Tbk Shares Held by Bristol-Myers Squibb Company in Asia
November 2, 2009 --We are pleased to announce that Taisho Pharmaceutical Co., Ltd. (Head Office: Tokyo, Japan; "Taisho") has completed the acquisition on October 30, 2009 (Jakarta time; late-night October 31, 2009 Japan...
Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
San Diego, CA - November 1, 2009 and Osaka, Japan - November 2, 2009 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that they have entered into a...
Bicycle Therapeutics and Pepscan enter into partnership to apply constrained peptide technology in the development of novel biotherapeutics
November 01, 2009--Bicycle Therapeutics has obtained a global license from Pepscan to utilize its proprietary constrained peptide chemistry technology. The parties propose to closely collaborate on the development of...
MERGE HEALTHCARE AND MEDRAD EXPAND EUROPEAN UNION DISTRIBUTION AGREEMENT
Milwaukee, WI, October 30, 2009 - Merge Healthcare (NASDAQ: MRGE), a health IT solutions leader, and MEDRAD, a leading provider of medical devices and services for diagnostic imaging, today announced an expansion of...
Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal Cancer Patients to Benefit from State-of-the-Art RapidArc and Novalis Tx Installations
PORTO, Portugal, Oct. 30, 2009-- Cancer patients in northern Portugal will gain access to advanced cancer treatments with the acquisition of seven new treatments machines from Varian Medical Systems (NYSE: VAR) by the...
Valeant to Acquire Polish Products
ALISO VIEJO, Calif., Oct. 30, 2009-- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it has agreed to acquire the rights to several prescription and cosmetic dermatology products from a...
Canadian authorities grant product approval for Intercell's Vaccine to prevent Japanese Encephalitis
Vienna, Austria, October 30, 2009 - Intercell AG (VSE: ICLL) today announced that the Health Canada granted product approval for IXIARO
DSM to further explore growth opportunities in China
Heerlen,NL,30-Oct-2009 08:15 CET --Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that the contracts to establish nutrition and anti-infectives...
Uppsala University renews Simcyp academic licenses
30 Oct 2009--Simcyp is pleased to announce that Uppsala University, Sweden, has renewed its academic license agreement.
Sanofi-aventis to Acquire Oenobiol, French Leader in Nutritional Beauty Supplements
Paris, France - October 30, 2009 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that it has entered into an agreement to acquire the company Laboratoire Oenobiol ("Oenobiol"), the French leader in...
Avesthagen brings French seeds giant Limagrain on board Atash Seeds in an IP based deal. The announcement was made in presence of Her Excellency Mrs. AnneMarie Idrac, Minister for Foreign Trade, Republic of France
Hyderabad, October 29, 2009:--AVESTHAGEN LIMITED today in the presence of Her Excellency Mrs. Anne Marie Idrac, Minister for Foreign Trade, Republic of France announced the formation of a joint venture company (JV)...
Norgine acquires cetilistat
October 26, 2009 -- Norgine BV today announced that it has purchased cetilistat, a novel treatment for obesity from Alizyme Therapeutics Limited. Norgine has acquired global rights to the product, including an...
Champions Biotechnology Expands Collaboration to Test Oncology Therapeutic in Biomerk Tumorgrafts(TM)
October 26, 2009 - Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has...
Case Western Reserve University, University Hospitals Case Medical Center and Bioptigen Establish Exclusive Licensing Agreement
CLEVELAND and RESEARCH TRIANGLE PARK, N.C. - October 24, 2009 - Case Western Reserve University and University Hospitals Case Medical Center have granted to Bioptigen, of Research Triangle Park, N.C ., an exclusive...
Merck and Schering-Plough Receive Approval From European Commission for Merger
WHITEHOUSE STATION, N.J. & KENILWORTH, N.J.---Oct. 23, 2009-- Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they have received clearance from the European Commission (EC)...
Potentia Pharmaceuticals Enters into Licensing and Purchase Option Agreements with Alcon (October 2009)
LOUISVILLE, Ky., Oct. 23, 2009 -- Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration (AMD), announced today that it has entered...
Paladin Labs Inc. Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research From Gates Foundation
MONTREAL, CANADA--(Oct. 23, 2009) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company announced today that its Paladin Biosciences division has received a US$100,000 Grand Challenges...
Exclusive Distribution Agreement with Rosetta Genomics Inc.
October 23, 2009 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to advise that it has executed an Exclusive Test and Services Agreement with Rosetta Genomics Inc. ("Rosetta"), under which the...
Merck and Schering-Plough Receive Approval From European Commission for Merger
WHITEHOUSE STATION and KENILWORTH, N.J., October 23, 2009 - Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) today announced that they have received clearance from the European Commission (EC)...
BD Announces Agreement to Acquire HandyLab, Inc.
Franklin Lakes, NJ (October 23, 2009) -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it signed a definitive agreement to acquire HandyLab, Inc., an Ann Arbor, Michigan-based company that develops...
Strategic Collaboration with Kineta
MATTAWAN, MI October 23, 2009: MPI Research announced that it will be collaborating with Kineta, Inc, a Seattle-based biotechnology company, in advancing their promising autoimmune drug development program. This...
Rosetta Genomics Names Genetic Technologies Limited Exclusive Distributor for Rosetta's microRNA-based Assays in Australia, New Zealand and Singapore
REHOVOT, Israel & PHILADELPHIA & MELBOURNE, Australia---Oct. 22, 2009-- Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG)...
Dual-labeled probe manufacturing license agreement
October 22, 2009 -- Eurogentec S.A. ("Eurogentec") announced today that it has obtained a license from Applied Biosystems', part of Life Technologies Corporation, ("AB") under AB's Probe Manufacturing License Program....
Covalon and Amsino International advance joint activities
MISSISSAUGA, Ontario - October 22, 2009 - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSX-V: COV), an advanced medical products company, announced that they have entered into a manufacturing agreement with...
Evotec Receives a EUR 2.5 Million Milestone Payment in its Research Collaboration with Boehringer Ingelheim
Hamburg, Germany - October 22, 2009: Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC) today announced that it has achieved another milestone in its research collaboration with Boehringer Ingelheim. The...
SKion GmbH makes a new, improved Tender Offer for Acquisition of ALTANA Shares
Wesel, October 22, 2009--Today SKion GmbH informed us about their decision to make a new, improved offer for the acquisition of shares in ALTANA AG and they have published this decision today according to
Corvitex and to-BBB join forces to raise funds in the USA
Raleigh (NC, USA), Leiden (Netherlands), October 21st 2009 - Corvitex, the US based global market services firm, and to-BBB, the Dutch brain drugdelivery company, have signed a "Marketing & Sales Support Agreement." The...
Institute for Systems Biology, Agilent Technologies to Build MRM Atlas for Quantification of All Human Proteins
SEATTLE, Wash., and SANTA CLARA, Calif., Oct. 21, 2009--The Institute for Systems Biology (ISB) and Agilent Technologies Inc. (NYSE: A) today announced a collaboration to create the Human Multiple Reaction Monitoring...
PharmaGap Announces Completion of Securities Lending Arrangements with Stormont.
Ottawa, Ontario/October 21, 2009 - PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) ("PharmaGap" or "the Company") today advises that the Securities Lending Agreements ("SLA") between SC Stormont Holdings Inc. ("Stormont")...
Illumina Announces Roadmap to Five Million Variants for Next-Generation Whole-Genome Genotyping
HONOLULU--Oct. 21, 2009-- At the 59th annual meeting of the American Society of Human Genetics, Illumina, Inc. (NASDAQ:ILMN) today announced its 2010 roadmap for the Infinium whole-genome genotyping platform, offering...
Gamida Cell and Cellerix Partner on Feasibility Study
Jerusalem, Israel and Madrid, Spain, October 21, 2009 --- Gamida Cell Ltd. and Cellerix, S.A. announced today that the companies are collaborating on a feasibility study to evaluate the added value of combining the...
Avacta Group plc Placing
October 21, 2009--Avacta Group plc ("Avacta" or "the Company"), the biophysics company which provides innovative high value technologies and services to the pharmaceutical and diagnostics markets, announces that it...
Sanofi-aventis and Wellstat Therapeutics enter into an Exclusive Worldwide Licensing Agreement for novel oral agent to treat Type II Diabetes
Paris, France - October 21, 2009 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Wellstat Therapeutics Corporation announced today a global licensing agreement on PN2034, a novel oral first-in-class, insulin...
Novavax and Xcellerex Announce Collaboration to Develop Large-scale Manufacturing Process for 2009 H1N1 Influenza VLP Vaccine
Rockville, MD and Marlborough, MA - October 21, 2009 - Novavax, Inc. (NASDAQ: NVAX) and Xcellerex, Inc. has entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process...
SemBioSys provides an update on Botaneco
CALGARY, Oct. 21, 2009 - SemBioSys Genetics Inc. ("SemBioSys") (TSX:SBS) today announced that Advitech Inc. ("Advitech") has entered into a definitive agreement to acquire all of the issued and outstanding shares of...
ScImage Receives Canadian Medical Device Licence for PicomEnterprise
Los Altos, CA - October 21, 2009 - ScImage, a leading enterprise imaging and informatics company, announced today that it has received a Class II Medical Devices Licence from Health Canada. The issued licence clears...
Lpath Receives Grants From the National Institutes of Health and Publishes Key Paper in the Proceedings of the National Academy of Sciences
SAN DIEGO, CA, October 20, 2009 -- The National Cancer Institute's Small Business Innovation Research (SBIR) Program has awarded Lpath (OTCBB: LPTN), the category leader in lipidomics-based therapeutics, two Phase 1...
Agfa HealthCare's DX-S System Recognized for Advances in Neonatal Imaging by Premier Healthcare Alliance
Mortsel, Belgium/ Greenville, SC (U.S.) October 20, 2009 CR is a technology that allows X-rays to be digitally captured, reviewed and archived. The DX-S CR system uses groundbreaking technologies, proprietary to Agfa...
Evotec Signs Agreement with DiscoveRx Corporation to Support High Throughput Screening Services
Hamburg, Germany / Oxford, UK - October 20, 2009 - Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC), a leading provider in the discovery and development of novel small molecule drugs and DiscoveRx Corporation...
Icagen Describes Progress in Its Collaboration With Pfizer to Identify Selective Sodium Channel Inhibitors
RESEARCH TRIANGLE PARK, N.C., October 19, 2009 -- Icagen, Inc. (Nasdaq:ICGN) today announced that data related to its collaboration with Pfizer focused on certain sodium channels for the treatment of pain and related...
New Pfizer Animal Health is Unveiled with Acquisition of Wyeth
NEW YORK--October 19, 2009--A new Pfizer Animal Health was unveiled last week as Pfizer's acquisition of Wyeth, including its subsidiary Fort Dodge Animal Health, was completed. Pfizer Animal Health is now the world's...
Maxxam Analytics acquires CANTEST, BC's leading independent laboratory
MISSISSAUGA, ON, and BURNABY, BC, October 19, 2009 - Maxxam Analytics International Corporation - an OMERS Private Equity portfolio company - announced today that it has acquired Burnaby, BC-based CANTEST Ltd.,...
Agfa HealthCare installs first DX-D 500 digital X-ray room in France, signs agreement for second installation
Mortsel, Belgium October 16, 2009 Uniting the digital technology of the DX-D 500 with MUSICA2 image processing optimized for DR, users of the solution can obtain immediate previews on the company's advanced NX...
Agfa HealthCare completes ten-site PACS and CR installation at Spire Healthcare Group in the United Kingdom
Morstel, Belgium/Brentford, UK October 15, 2009 Spire Healthcare is the UK's second largest private hospital provider. Following a number of recent acquisitions, the Group's network now numbers 36 facilities and covers...
Evotec Extends Medicinal Chemistry Collaboration with Ono Pharmaceutical Co., Ltd.
Hamburg, Germany - October 15, 2009 - Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC) today announced that it has extended its current research collaboration with Ono Pharmaceutical Co., Ltd. (Ono) and initiated...
NAMSA Forms New Partnerships for Sterilization Monitoring Products in Sri Lanka & Bangladesh
October 14, 2009 -- NAMSA, a worldwide leader in the safety evaluation of medical devices and manufacturer of sterilization assurance products, is pleased to announce our new partnerships with Package Care (Pvt) Ltd. of...
Affymetrix Announces Major Genotyping Project With Kaiser Permanente and the University of California at San Francisco for NIH-Funded Epidemiology Study
SANTA CLARA, Calif.--Oct. 14, 2009-- Affymetrix, Inc. (Nasdaq:AFFX) today announced that the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and the University of California at San Francisco...
Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University
TROY, Mich., Oct. 14, 2009-- Somanetics Corporation (Nasdaq: SMTS) today announced that it has signed an Exclusive Sublicense Agreement with Raba Equity Partners II, LLC ("Raba coreFoundry"). Under terms of the...
Dainippon Sumitomo Pharma Co., Ltd. and Sepracor Inc. Announce Successful Tender Offer and Commencement of Subsequent Offering Period
OSAKA, Japan & MARLBOROUGH, Mass.---Oct. 14, 2009-- Dainippon Sumitomo Pharma Co., Ltd. ("DSP") and Sepracor Inc. ("Sepracor") (NASDAQ: SEPR) today announce the successful completion of the tender offer by DSP's...
BioSante Pharmaceuticals and Cell Genesys Announce Completion of Merger
LINCOLNSHIRE, Ill. & SOUTH SAN FRANCISCO, Calif.--Oct. 14, 2009-- BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) and Cell Genesys, Inc. (NASDAQ:CEGE), today announced the successful completion of their previously...
PURE Bioscience Expands Business Strategy with Sales and Marketing Alliance for Long-Lasting, Broad Spectrum SDC Antimicrobial Products
San Diego, CA, Oct. 14, 2009 - PURE Bioscience (NASDAQ: PURE) announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont Sciences, LLC, which will...
Pressure BioSciences, Inc. and Protein Forest, Inc. Announce Collaborative Co- Marketing/Selling and R&D Agreement
South Easton, MA, October 14, 2009 - Pressure BioSciences, Inc. (NASDAQ: PBIO) ("PBI") and Protein Forest, Inc. ("Protein Forest"), (together "the companies"), today announced that they have entered into a strategic...
VAXIN LAUNCHES JOINT VENTURE WITH ANC BIO IN KOREA
Birmingham, Alabama - October 14, 2009 - Vaxin Inc., an emerging vaccine company today announced that it has entered into a joint venture with South Korean biomedical company, AnC Bio Group to develop, manufacture and...
Eckert & Ziegler awards grants to young researchers in nuclear medicine
Berlin, October 14, 2009. This year's travel grants from Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE 0005659700) have been awarded to five nuclear medicine scientists from Germany, Italy, Poland and...
Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc
Mechelen, Belgium 14 October 2009 - Galapagos NV (Euronext: GLPG) announced today that it has expanded its global strategic alliance in metabolic diseases with an affiliate of Merck & Co., Inc to incorporate the...
European Medicines Evaluation Agency Grants Orphan Drug Designation to ARQ 197 for Treatment of Soft Tissue Sarcoma
WOBURN, Mass.--Oct. 14, 2009-- ArQule, Inc. (NASDAQ: ARQL) today announced that the European Medicines Evaluation Agency (EMEA) has designated ARQ 197 as an orphan medical product for the treatment of soft tissue...
ONCOLYS BIOPHARMA SIGN STRATEGIC ALLIANCE AND LICENSE AGREEMENT WITH ASTELLAS PHARMA TO DEVELOP AND COMMERCIALIZE YM753 HDAC INHIBITOR DRUG
Tokyo, Japan -- October 13, 2009 -- Oncolys BioPharma Inc. (headquarters: Tokyo; President and CEO: Yasuo Urata) announced today that it has entered into a strategic alliance and license agreement with Astellas Pharma...
Amarin Corporation PLC (AMRN) Announces $70 Million Private Placement
DUBLIN--October 13, 2009--Amarin Corporation plc today announced it has entered into a definitive agreement with several existing and new institutional and accredited investors for a $70 million private placement.
SRI International Awarded a Department of Defense "Laboratory-Clinical Transition" Grant to Advance SRI's Novel Anticancer Agents for Prostate Cancer Treatment
MENLO PARK, Calif. --October 13, 2009--SRI International, an independent, nonprofit research and development organization, announced today that it has been awarded a $1.55M U.S. Department of Defense/Prostate Cancer...
GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
Issued: 13 October 2009, London, UK & Leiden, The Netherlands - GlaxoSmithKline (GSK) and Prosensa, the Dutch based biopharmaceutical company focusing on RNA modulating therapeutics, today announced that they have...
Scripps Research Scientists Illuminate Structure of Circulating Lung Cancer Cells
LA JOLLA, CA, October 13, 2009 - Most cancer-related deaths are caused by metastases - the spread of cancer to other parts of the body - and tumor cells that circulate in the bloodstream are generally understood to be...
Sequella Obtains Funding to Continue Expansion of its Anti-infectives Pipeline
Rockville, Md. - October 12, 2009--- Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it...
Share Option Grant
London, UK, 12 October 2009 - Lombard Medical Technologies PLC (AIM: LMT), the specialist medical device company, announces that it has today granted 33,652,191 share options to its newly appointed CEO, John Rush.
"Biology in Balance"
Paris (France), 12 October 2009 - In a continuing series called "Exciting Biologies" Cell Press, Massachusetts General Hospital and La Fondation Ipsen collaborate to offer annual meetings designed to highlight emerging...
KIMBERLY-CLARK ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE I-FLOW CORPORATION
DALLAS and LAKE FOREST, Calif., October 9, 2009 - Kimberly-Clark Corporation (NYSE: KMB) and I-Flow Corporation (NASDAQ: IFLO), a leading healthcare company that develops and markets technically advanced, low-cost drug...
The Institute of Cancer Research and The Royal Marsden Honoured with Oncology Award
October 09, 2009 -- A programme to improve cancer pain management has won The Institute of Cancer Research (ICR) in collaboration with The Royal Marsden NHS Foundation Trust recognition for the Best Professional...
MDS Announces Agreement to Sell Central Labs Operation to Czura Thornton
TORONTO, October 9, 2009 - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs...
Ipsen acquires exclusive marketing rights of BLI-800 from Braintree for colonic cleansing before colonoscopy
Braintree (Massachusetts, United States) and Paris (France), 9 October 2009 - Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group and Braintree Laboratories, Inc., a US-based...
FDA Awards $17.5 Million in Grants to Further Food and Feed Safety
October 9, 2009 -- The U.S. Food and Drug Administration today announced that it has awarded 83 grants in FY2009 totaling $17.5 million to state and local regulatory agencies to boost food and feed safety initiatives...
SOLVAY AND HUATAI TO JOINTLY BUILD HYDROGEN PEROXIDE PLANT IN CHINA
October 9, 2009--Solvay today announces that it has struck an agreement with Huatai Group of China to establish a Hydrogen Peroxide joint venture. The joint venture company, Shandong Huatai Interox Chemical Co Ltd, will...
Skymark Research Initiates Independent Research Coverage On MedaSorb Technologies Corp
CALGARY, Alberta, Oct. 8, 2009 -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on MedaSorb Technologies Corp. (OTCBB:MSBT - News). Skymark...
Claros Diagnostics Receives ISO 13485 Certification
WOBURN, Mass.--October 08, 2009--Claros Diagnostics, a developer of novel point-of-care immunoassay systems, reported the receipt of corporate ISO 13485 and CMDCAS certificates of registration issued by the National...
Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
LAKE FOREST, Ill., October 8, 2009 -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today signed a Business Cooperation Agreement with South Korea-based Celltrion, Inc. and Celltrion...
Vitrolife signs collaboration agreement with Cellartis
October 08, 2009--Vitrolife has entered into a new 3-year collaboration agreement with Cellartis AB regarding the development of new products for the culture, handling and differentiation of stem cells. The agreement...
Bayer Schering Pharma collaborates with AC Immune in the field of Alzheimer
Berlin, Germany, October 8, 2009 - Bayer Schering Pharma AG, Germany, will provide its development candidate florbetaben, a so called PET (positron emission tomography) tracer, to the Swiss-based biopharmaceutical...
United BioSource Corporation Receives $125 Million Growth Equity Investment
October 08, 2009--United BioSource Corporation today announced that Berkshire Partners LLC, a Boston-based private equity firm, has made a $125 million growth equity investment to support the Company's evidence-based...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
